Gainers & Losers

YOU ARE ON :
  • HOME /
  • IPO /
  • IPO ISSUES /
  • IPO-SYNOPSIS

Senores Pharmaceuticals Ltd

Registered Office: #.1101-1103 11th Flr South Twr,Ambali Bopal Road, Ahmedabad - 380054, Gujarat, India.
Phone : +91-79-2999 9857   Fax:
Email :  cs@senorespharma.com  
Website :  www.senorespharma.com

Initial public offering of 14,887,723 equity shares of face value of Rs. 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of Rs. 391 per equity share (including a share premium of Rs. 381 per equity share) ("Offer Price") aggregating to Rs. 582.11 crores (the "Offer"). The offer comprises of a fresh issue of 12,787,723 equity shares by the company aggregating to Rs. 500.00 crores (the "Fresh Issue") and an offer for sale of 2,100,000 equity shares (the "Offered Shares") aggregating to Rs. 82.11 crores (the "Offer for Sale"), comprising 250,000 equity shares aggregating to Rs. 9.78 crores by Swapnil Jatinbhai Shah, 550,000 equity shares aggregating to Rs. 21.51 crores by Ashokkumar Vijaysinh Barot, 300,000 equity shares aggregating to Rs. 11.73 crores by Sangeeta Mukur Barot and 1,000,000 equity shares aggregating to Rs. 39.10 crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute 32.33 % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of 75,000 equity shares, aggregating to Rs. 2.93 crores constituting 0.16% of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The face value of the equity shares is Rs. 10 each and the offer price is 39.10 times the face value of the equity shares.

Issue Money Payable On
Opens on Closes On Application Allotment
20-Dec-24 24-Dec-24 391.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 38   Further Multiples of : 38
  Rs(Cr.) Lead Managers to the Issue
Project Cost 457.81 Ambit Pvt Ltd
Project Financed through Current Offer 582.11  
Post Issue Equity Share Capital 46.05  
Issue Price 391.00  

Project

  • Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility
  • Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI
  • Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris
  • Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
  • Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries
  • Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements

Promoted By

Swapnil Jatinbhai

Ashokkumar Vijaysingh Barot

Anar Swapnil Shah

Listing At

BSE

NSE

Registrar to the Issue

MUFG Intime India Pvt Ltd

Attention Investor:

1) "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         2) For Stock Broking Transaction "Prevent unauthorised transactions in your account Update your mobile numbers / email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .... Issued in the interest of Investors."         3) For Depository Transaction "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....Issued in the interest of investors."         4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.